{
  "ptid_time": "136_S_0194_2006-04-10",
  "img_path": "/data/qiuhui/data/adni/images/136_S_0194/2006-04-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 21,749 mm³, 41.2% below the reference mean. With a Z-score of -1.11 (13.3th percentile), this represents mild atrophy; hippocampal volume measures 5,614 mm³, 13.6% below the reference mean. With a Z-score of -1.09 (13.9th percentile), this represents mild atrophy; whole brain volume measures 823,885 mm³, 11.2% below the reference mean. With a Z-score of -1.35 (8.9th percentile), this represents mild atrophy; entorhinal cortex volume measures 2,257 mm³, 34.8% below the reference mean. With a Z-score of -1.88 (3.0th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,562 mm³, 9.6% below the reference mean. With a Z-score of -0.72 (23.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 14,161 mm³, 21.5% below the reference mean. With a Z-score of -1.91 (2.8th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 80.5 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 24.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 671.20 pg/mL (normal ); Total tau: 494.60 pg/mL (profound elevated); Phosphorylated tau: 52.52 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild to moderate atrophy in key regions associated with Alzheimer's disease (AD), including the hippocampus, entorhinal cortex, and middle temporal gyrus. The CSF biomarkers (normal Aβ but profoundly elevated T-tau and P-tau) suggest AD pathology despite the absence of APOE4. The MMSE score of 24 indicates mild cognitive impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **Medium** (CSF biomarkers strongly support AD pathology, but the absence of APOE4 and only mild cognitive symptoms introduce some uncertainty)",
  "timestamp": "2025-07-26T15:58:31.209567"
}